Ylva Naeser
Doktorand vid Institutionen för immunologi, genetik och patologi; Forskningsprogram: Cancerimmunterapi; Forskargrupp Gustav Ullenhag
- E-post:
- ylva.naeser@igp.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala - Postadress:
- Akademiska sjukhuset, ingång 100/101
751 85 Uppsala
Publikationer
Senaste publikationer
-
Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study
Ingår i International Journal of Cancer, s. 2581-2591, 2026
- DOI för Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study
- Ladda ner fulltext (pdf) av Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study
-
Ingår i The Lancet Oncology, s. 1501-1510, 2025
-
The role of imaging in follow-up and prognosis of patients radically operated for melanoma
2024
-
Ingår i eClinicalMedicine, 2023
- DOI för Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
- Ladda ner fulltext (pdf) av Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
-
Ingår i Cancers, 2022
- DOI för Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
- Ladda ner fulltext (pdf) av Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
Alla publikationer
Artiklar i tidskrift
-
Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study
Ingår i International Journal of Cancer, s. 2581-2591, 2026
- DOI för Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study
- Ladda ner fulltext (pdf) av Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study
-
Ingår i The Lancet Oncology, s. 1501-1510, 2025
-
Ingår i eClinicalMedicine, 2023
- DOI för Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
- Ladda ner fulltext (pdf) av Survival in patients diagnosed with melanoma in situ compared to the general population. A Swedish population-based matched cohort study
-
Ingår i Cancers, 2022
- DOI för Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
- Ladda ner fulltext (pdf) av Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
-
Ingår i Clinical Oncology: Case Reports, 2021
-
Ingår i BMC Cancer, 2020
- DOI för TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma
- Ladda ner fulltext (pdf) av TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma
-
Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
Ingår i PLOS ONE, 2017
- DOI för Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
- Ladda ner fulltext (pdf) av Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer